Unit

UNIT 9.10 Use of Proteasome Inhibitors

  1. Sondra L. Downey1,
  2. Bogdan I. Florea2,
  3. Herman S. Overkleeft2,
  4. Alexei F. Kisselev1

Published Online: 1 APR 2015

DOI: 10.1002/0471142735.im0910s109

Current Protocols in Immunology

Current Protocols in Immunology

How to Cite

Downey, S.L., Florea, B.I., Overkleeft, H.S., and Kisselev, A.F. 2015. Use of Proteasome Inhibitors. Curr. Protoc. Immunol. 109:9.10.19.10.9. doi: 10.1002/0471142735.im0910s109

Author Information

  1. 1

    Norris Cotton Cancer Center and Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire

  2. 2

    Gorlaeus Laboratories, Leiden Institute of Chemistry and Netherlands Proteomics Centre, Leiden, The Netherlands

Publication History

  1. Published Online: 1 APR 2015

Abstract

Proteasome inhibitors are indispensable research tools in immunology and cell biology. With numerous proteasome inhibitors available commercially, choosing the appropriate compound for a biological experiment may be challenging, especially for a novice. This unit provides an overview of the proteasome inhibitors commonly used in research. It discusses how to select an appropriate highly specific inhibitor, its concentration, and length of exposure for mammalian cell culture experiments. In addition, assays that can be used to confirm proteasome inhibition are discussed. © 2015 by John Wiley & Sons, Inc.

Keywords:

  • proteosome inhibitors;
  • peptide aldehydes;
  • boronates;
  • peptide epoxyketones